ten23 health, a Swiss contract development and manufacturing organization (CDMO), is collaborating with BD (Becton, Dickinson and Company), to assist with the commercialization of its wearable injectable, BD Libertas.¹

How will the BD Libertas wearable injector and ten23’s CDMO services work together?

The partnership is expected to provide biopharma companies with a product that offers the subcutaneous delivery of large-volume drugs, accelerating development, while lowering risk in complex injectable programs in the process.

By combining the BD Libertas wearable on-body injector (OBI) with 5 mL or 10 mL BD glass cartridges and the likes of CDMO’s development, aseptic filling, assembly, and quality operations, pharma partners will be able to leverage a scalable injector platform and manufacturing infrastructure to bring high-volume subcutaneous (SC) treatments to patients without sacrificing flexibility or usability.

Why is supply chain readiness critical for commercializing wearable injectables?

The goal of BD’s proprietary wearable injector is to provide a ready-to-use, wearable injector that can be used for the subcutaneous administration of high-dose biologics, which allows the industry to shift biologics from intravenous to SC delivery. The involved parties are aiming to facilitate “supply chain readiness” that supplements commercialization, while simplifying any regulatory pathways that are encountered.

“Enabling successful patient treatment on behalf of our customers is a key priority for ten23. Based on the already successful collaboration of ten23 with BD for the BD iDFill solution (RFID-enabled PFS/containers), we are happy to expand our collaboration to also include BD Libertas Wearable Injector platform,” said Prof. Hanns-Christian Mahler, PhD, ten23 health’s chief enablement officer, in a company news release.¹ “Our unique offerings and experiences with a range of devices make ten23 an ideal partner for any SC delivery options.”

Hanns-Christian Mahle is referring to ten23 health’s and BD’s professional relationship that dates back to October 2024, when the companies teamed up to design a new way to track prefillable syringes (PFS) with the help of radio frequency identification (RFID) technology. One of the end goals has been to boost manufacturing process efficiency.²

How does BD iDFill improve traceability and manufacturing efficiency?

The objective of the partnership was to test an RFID-based solution designed by BD to that is expected to augment and add efficiencies to the manufacturing process, while also providing unit-level traceability. In turn, ten23 health customers would be able to experience greater traceability, not only throughout the entire manufacturing process, but within the supply chain overall.

It was coined BD iDFill Individual Prefillable Syringe Identification, but in order for this effort to be successful, each PFS must be equipped with an RFID tag that’s programmed with a unique serial number known as the container unique identifier (CUID), which is able to be scanned at multiple steps of the manufacturing process. All the necessary drug codes, filling batches, and timestamps—along with other data—are linked to the CUID, which activates that traceability factor.

“BD iDFill aims to transform the way we approach quality and efficiency in the fill & finish process by extending the role of the PFS from a drug container to a digital enabler,” said Patrick Jeukenne, president of BD Medical - Pharmaceutical Systems.¹ “We expect this innovation will harness the vast potential of data in manufacturing and bring a new level of transparency to the pharmaceutical fill & finish process.”

Reference

1. ten23 health and BD Partner to Enable Supply Chain Readiness of BD Libertas Wearable Injector as Full-Service Solution. ten23 health. January 20, 2026. Accessed January 20, 2026. https://www.ten23.health/fileadmin/files/downloads/press_releases/20260120_ten23_BDLibertas_Partnership.pdf

2. BD and ten23 health Partner to Advance Efficiency and Quality in Aseptic Manufacturing With RFID-Enabled Prefillable Syringes. BD. October 8, 2024. Accessed January 20, 2026. https://www.ten23.health/fileadmin/files/downloads/press_releases/20260120_ten23_BDLibertas_Partnership.pdf